Renin-angiotensin-aldosterone system inhibitors were linked to better pediatric chronic kidney disease outcomes compared with ...

Angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor antagonists have become an important tool for the treatment of hypertension and its cardiovascular complications. Inhibition ...

Multiple recent studies highlight the renin-angiotensin-aldosterone system (RAAS) as a critical factor in COVID-19 severity, with ACE2 dysregulation influencing inflammation, vascular damage, and ...

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

Cost-effectiveness of NALIRIFOX compared to other first-line treatments for metastatic pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...

pills Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators. Halting renin-angiotensin system (RAS) inhibitors in ...

Inhibitor of differentiation-1 (Id1) characterization in poor prognosis (PP) hormone-refractory (HR) metastatic prostate cancer (CaP) primary tumors and matched metastases (MTS) using a new monoclonal ...

Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019 (COVID-19). In silico docking and molecular dynamics studies have shown ...

Your kidneys aren’t just filters—they’re also hormone hubs that help control blood pressure, calcium, and bone health. Hormones like parathyroid hormone, calcitonin, and those in the renin–angiotensin ...